What are the options for hepatocellular carcinoma patients who progress under sorafenib?

ABSTRACT:

SUBMITTER: Lau EY 

PROVIDER: S-EPMC6095157 | biostudies-literature | 2016 Apr

REPOSITORIES: biostudies-literature